The companies plan to test the treatment's efficacy in preclinical models of squamous cell lung carcinoma early next year.

The firm said treatment with the autologous immunotherapy demonstrated increased overall survival compared to placebo in a Phase II study.

Project GENIE will use the funding to build an AI-based tool to perform multilingual clinical data translation and expand global access to the registry.

The firm received guidance from the FDA during a recent type B meeting on the study's inclusion criteria, design, and statistical parameters.

Trontinemab, designed to reach the brain better than gantenerumab, led to amyloid negativity in 92 percent of patients at the ...

The agency is proposing drugmakers use shorter nonrodent studies and other sources of evidence when developing monoclonal antibodies for non-cancer settings.